Rare diseases
Investigational molecules
Locations
Back to Hungary62 clinical trials in Szombathely, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis
HungaryStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
HungaryStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
HungaryStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
HungaryStudy of Different Doses of Amlitelimab Given by Injection Under the Skin in Adults with Moderate to Severe Asthma
HungaryStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
HungaryStudy on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
HungaryStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
HungaryStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
HungaryComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
HungaryA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
HungaryComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
HungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on respiratory conditions, particularly investigating new treatments for asthma and COPD. Studies evaluate innovative therapies including atuliflapon and dupilumab for improving lung function and disease control.
Research aims to enhance therapeutic options for patients with uncontrolled respiratory conditions.
Innovative research in inflammatory skin conditions and immune-mediated disorders, including studies on atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa.
Studies focus on developing targeted treatments for chronic inflammatory conditions.
Groundbreaking research in cancer treatment and blood disorders, including studies on breast cancer, lymphoma, and multiple myeloma. Investigations of targeted therapies and combination treatments.
Focus on improving survival rates and treatment outcomes in various cancer types.
Clinical research examining treatments for inflammatory bowel diseases, including studies on Crohn's Disease and Ulcerative Colitis. Evaluation of combination therapies and novel biological agents.
Emphasis on improving quality of life for patients with chronic digestive conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
